Evercore ISI assumed coverage on shares of Ortho Clinical Diagnostics (NASDAQ:OCDX) in a research note released on Monday, The Fly reports. The brokerage issued an outperform rating and a $26.00 target price on the stock.
A number of other equities research analysts have also recently weighed in on OCDX. Credit Suisse Group began coverage on shares of Ortho Clinical Diagnostics in a research report on Monday. They issued an outperform rating and a $21.00 price target for the company. Wolfe Research began coverage on Ortho Clinical Diagnostics in a report on Monday. They issued a market perform rating for the company. HC Wainwright started coverage on Ortho Clinical Diagnostics in a research note on Monday. They set a buy rating and a $27.00 price target on the stock. Piper Sandler initiated coverage on Ortho Clinical Diagnostics in a research note on Monday. They issued an overweight rating for the company. Finally, Citigroup assumed coverage on Ortho Clinical Diagnostics in a report on Monday. They issued a buy rating and a $20.00 price objective for the company. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. Ortho Clinical Diagnostics presently has a consensus rating of Buy and an average price target of $24.00.
Shares of NASDAQ:OCDX opened at $17.11 on Monday. Ortho Clinical Diagnostics has a twelve month low of $15.14 and a twelve month high of $18.65.
Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business in the United States. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a broad spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases.
Read More: What does a bar chart mean for investors?
Receive News & Ratings for Ortho Clinical Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Clinical Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.